Back to Archived News
MMRGlobal Continues to Add to Its Patent Portfolio
Monday, January 24, 2011
Los Angeles, CA -- MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") today announced that it has added New Zealand to its list of Patent awards for its Method and System for Providing Online Medical Records in connection with its MyMedicalRecords Personal Health Record ("PHR") product and services. This patent covers document delivery and emergency log-in services of the Company's global Personal Health Record technology.
Patents have been either issued or are pending in more than 13 countries of interest. The Company's PHR patent portfolio has been the subject of worldwide rigorous examination and creates a significant licensing opportunity to companies providing Electronic Medical Records("EMR") or electronic health information services globally. The PHR patent portfolio is in addition to MMRGlobal's portfolio of biotech patents which it acquired and resurrected from its merger with Favrille, Inc., a San Diego biotech company, in January 2009. The biotech portfolio of patents for its B-cell vaccine and anti-CD20 antibody related intellectual property was created at a cost of over 140 million dollars. The Company believes that the value of the portfolio could be significant, representing licensing opportunities and strategic business opportunities with universities and other biotech companies.
Robert H. Lorsch, MMRGlobal Chairman and CEO, said, "The Company's PHR patents were filed nearly five years ago to ensure that there would be a significant barrier to entry to competitors offering Electronic Medical Records, Personal Health Record services and other similar services to those the Company provides. Consistent with its licensing activities in biotech, MMR will enter into agreements with EMR providers that we believe can generate significant revenue for the benefit of shareholders. More than 80% of all medical records in the world are moved by digital services, which the Company's patents specifically address, and our technology has been specifically designed to work with any other Electronic Health Record system in use today."
The Company continues to prosecute claims for its patents pertaining to its MyMedicalRecords Personal Health Record products and its professional healthcare IT solution for physicians and small hospitals, MMRPro, as well as its biotech and vaccine patents pending in all countries of commercial interest.
About MMRGlobal, Inc.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (MMR), provides secure and easy-to-use online Personal Health Records (PHRs) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. MMRGlobal's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.
Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan, " "could," "help" and "continue," or the negative of such terms and other comparable terminology. MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMRGlobal, Inc.'s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related but not limited to changes in MMRGlobal, Inc.'s business prospects, its results of operations or financial condition, government regulation and changes in healthcare initiatives, developing and defending its intellectual property rights including those pertaining to its biotech assets, and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.'s public filings with the U.S. Securities and Exchange Commission.
Back to Archived News